tert-butyl (S)-3-oxo-1-phenylheptan-2-ylcarbamate | 1277097-52-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: tert-butyl (S)-3-oxo-1-phenylheptan-2-ylcarbamate
• 英文别名: tert-butyl (1S)-1-benzyl-2-oxohexylcarbamate；tert-butyl N-[(2S)-3-oxo-1-phenylheptan-2-yl]carbamate
• CAS: 1277097-52-5
• 化学式: C₁₈H₂₇NO₃
• 分子量: 305.417
• InChiKey: SISLDZUNPJNPAR-HNNXBMFYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  22
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  55.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  tert-butyl (S)-3-oxo-1-phenylheptan-2-ylcarbamate 在 sodium tetrahydroborate 作用下， 以 乙醇 为溶剂， 反应 24.0h， 生成 tert-butyl (1S,2R)-1-benzyl-2-hydroxyhexylcarbamate 、 tert-butyl (2S,3S)-3-hydroxy-1-phenylheptan-2-ylcarbamate
  参考文献：
  名称：

  Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease

  摘要：

  本发明涉及苯胺和吡啶胺衍生物化合物，这些化合物是β-分泌酶的抑制剂，并且在治疗涉及β-分泌酶的疾病，如阿尔茨海默病中有用。该发明还涉及包含这些化合物的药物组合物，以及在治疗涉及β-分泌酶的这类疾病中使用这些化合物和组合物。

  公开号：

  US20070142634A1
• 作为产物：
  描述：

  BOC-L-苯丙氨酸 在 1-羟基苯并三唑 、 N,N'-二环己基碳二亚胺 作用下， 以 四氢呋喃 、 乙醚 、 二氯甲烷 为溶剂， 反应 12.17h， 生成 tert-butyl (S)-3-oxo-1-phenylheptan-2-ylcarbamate
  参考文献：
  名称：

  Access to Enantiomerically Enriched cis-2,3-Disubstituted Azetidines via Diastereoselective Hydrozirconation

  摘要：

  An asymmetric variant of the hydrozirconation reaction has been established starting from Boc-protected chiral allylic amines. The resulting diastereoselectively formed N-functionalized organozirconiums can be considered as promising chirons. In this case, they have been transformed into enantiomerically enriched cis-2,3-disubstituted azetidines through a iodination/cyclization sequence.

  DOI：

  10.1021/ol200323r

文献信息

• Access to Enantiomerically Enriched <i>cis</i>-2,3-Disubstituted Azetidines via Diastereoselective Hydrozirconation
  作者：Tarun K. Pradhan、K. Syam Krishnan、Jean-Luc Vasse、Jan Szymoniak

  DOI：10.1021/ol200323r

  日期：2011.4.1

  An asymmetric variant of the hydrozirconation reaction has been established starting from Boc-protected chiral allylic amines. The resulting diastereoselectively formed N-functionalized organozirconiums can be considered as promising chirons. In this case, they have been transformed into enantiomerically enriched cis-2,3-disubstituted azetidines through a iodination/cyclization sequence.
• Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease
  申请人：Barrow C. James

  公开号：US20070142634A1

  公开（公告）日：2007-06-21

  The present invention is directed to phenylamide and pyridylamide derivative compounds of which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.

  本发明涉及苯胺和吡啶胺衍生物化合物，这些化合物是β-分泌酶的抑制剂，并且在治疗涉及β-分泌酶的疾病，如阿尔茨海默病中有用。该发明还涉及包含这些化合物的药物组合物，以及在治疗涉及β-分泌酶的这类疾病中使用这些化合物和组合物。